NYSEMKT:DHY

Credit Suisse High Yield Bond Fund Stock News

etoro logo Buy DHY
*Your capital is at risk
$1.76
+0 (+0%)
At Close: Jun 03, 2026
CureVac has filed to raise $200 million in a U.S. IPO and another $118 million in a concurrent private placement.
CureVac, one of Germany's leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial public stock offering (IPO) on the U.S. Nasdaq.
This reporting season is described as the worst on record for the S&P/ASX 200 Index (Index:^AXJO). But there may be exceptions.
Xpeng's push for a New York IPO comes amid escalating tensions between the U.S. and China that have threatened Chinese firms listing on Wall Street.
CureVac aims to raise up to $245 million in U.S. IPO
KE Holdings has filed to raise $1.9 billion from the sale of ADSs in a U.S. IPO.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE